Clinical Trial Update: Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer

View source ↗

Summary

A clinical trial is investigating oral metronomic vinorelbine in combination with PD-1 inhibitors for elderly patients with non-small cell lung cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PD-1 inhibitors
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Anhui Chest Hospital | Conditions: Lung Cancer (NSCLC), Elderly (People Aged 65 or More) | Status: RECRUITING